2006
DOI: 10.1093/rheumatology/kel187
|View full text |Cite
|
Sign up to set email alerts
|

The measurement of outcome and the rheumatoid arthritis core set to lift the prejudice of the ‘thaumaturgus cliché’

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…The decision regarding choice of outcome measures should be based upon a core outcome set achieved through consensus, such as is the case with The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (PedIMMPACT, McGrath et al., ) and The Outcome Measures in Rheumatology (OMERACT, Tugwell et al., ). Although core outcomes in pediatrics are generally lacking (Chong et al., ), OMERACT and PedIMMPACT have contributed to improved trial feasibility (in these populations) and relevance and acceptability of trial endpoints on a global scale (Bertinotti, Nacci, & Matucci‐Cerinic, ; Sinha et al., ). This has not yet been addressed for VA outcomes, and in the context of a registry dataset, standardization of outcome measures and time points would be essential to positively impact the useability of registry data by researchers, clinicians, and health care.…”
Section: Discussionmentioning
confidence: 99%
“…The decision regarding choice of outcome measures should be based upon a core outcome set achieved through consensus, such as is the case with The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (PedIMMPACT, McGrath et al., ) and The Outcome Measures in Rheumatology (OMERACT, Tugwell et al., ). Although core outcomes in pediatrics are generally lacking (Chong et al., ), OMERACT and PedIMMPACT have contributed to improved trial feasibility (in these populations) and relevance and acceptability of trial endpoints on a global scale (Bertinotti, Nacci, & Matucci‐Cerinic, ; Sinha et al., ). This has not yet been addressed for VA outcomes, and in the context of a registry dataset, standardization of outcome measures and time points would be essential to positively impact the useability of registry data by researchers, clinicians, and health care.…”
Section: Discussionmentioning
confidence: 99%